Achondroplasia is a rare genetic condition arising from a systemic fibroblast growth factor receptor 3 (FGFR3) variant that leads to an imbalance in the effects of the FGFR3 and C-type natriuretic peptide signaling pathways, estimated to affect more than 250,000 people worldwide.1-11 While historically considered a skeletal condition, the FGFR3 variant seen in achondroplasia is expressed in tissues throughout the body, causing serious muscular, neurological, and cardiorespiratory complications in addition to skeletal dysplasia.1-8 Medical complications of achondroplasia vary across different stages of life.4,19 Throughout infancy and childhood, observed complications include spinal abnormalities, enlarged brain ventricles, impaired muscle strength and stamina, hearing deficits and chronic ear infections, upper airway obstructions, sleep-disordered breathing, hip problems, leg bowing, and chronic pain
By purchasing, you confirm that this product will be used solely for approved laboratory research purposes
This fraud model transcends simple financial theft by introducing direct health risks
22 El-BeltagiH
